Eur Respir J 1998; 11: 624-629
Copyright © ERS Journals Ltd 1998
Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice
H Shi,
A Yokoyama,
N Kohno,
Y Hirasawa,
K Kondo,
K Sakai,
and
K Hiwada
Thromboxane (Tx)A2 synthase inhibitors and thromboxane prostanoid (TP) receptor antagonists have been developed as anti-asthma drugs. TxA2 may contribute to airflow limitation and bronchial hyperresponsiveness, and these compounds have been demonstrated to improve them. However, it is not known whether TxA2 is involved in bronchial inflammation. To address this question, we explored the influences of OKY-046 (a TxA2 synthase inhibitor) and S-1452 (a TP receptor antagonist) on eosinophilic inflammation of the airways using a murine model. BALB/c mice sensitized with ovalbumin and challenged by repeated exposure to ovalbumin yielded marked eosinophilia in bronchoalveolar lavage fluid (BALF). Treatment with either compound significantly reduced the number of total cells and eosinophils in BALF in a dose-dependent manner. The production of interleukin (IL)-5, IL-2 and interferon (IFN)-gamma by antigen-stimulated splenic mononuclear cells (SMNC) was significantly decreased in mice treated with either compound compared to that in untreated mice. Furthermore, both compounds inhibited proliferation and cytokine production of SMNC in vitro. These results suggest that both OKY-046 and S-1452 are capable of inhibiting production of cytokines, which in turn inhibits eosinophil infiltration into the murine airway. Thus, both thromboxane A2 synthesis inhibitors and thromboxane prostanoid antagonists may be effective as anti-inflammatory drugs in the treatment of asthma.
This article has been cited by other articles:

|
 |

|
 |
 
A. T. Nials and S. Uddin
Mouse models of allergic asthma: acute and chronic allergen challenge
Dis. Model. Mech.,
November 1, 2008;
1(4-5):
213 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Y. Park and J. W. Christman
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases
Am J Physiol Lung Cell Mol Physiol,
May 1, 2006;
290(5):
L797 - L805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Peebles Jr, K. Hashimoto, J. R. Sheller, M. L. Moore, J. D. Morrow, S. Ji, J. A. Elias, K. Goleniewska, J. O'Neal, D. B. Mitchell, et al.
Allergen-Induced Airway Hyperresponsiveness Mediated by Cyclooxygenase Inhibition Is Not Dependent on 5-Lipoxygenase or IL-5, but Is IL-13 Dependent
J. Immunol.,
December 15, 2005;
175(12):
8253 - 8259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stokes Peebles Jr., K. Hashimoto, J. D. Morrow, R. Dworski, R. D. Collins, Y. Hashimoto, J. W. Christman, K.-H. Kang, K. Jarzecka, J. Furlong, et al.
Selective Cyclooxygenase-1 and -2 Inhibitors Each Increase Allergic Inflammation and Airway Hyperresponsiveness in Mice
Am. J. Respir. Crit. Care Med.,
April 15, 2002;
165(8):
1154 - 1160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. OGUMA, K. ASANO, T. SHIOMI, K. FUKUNAGA, Y. SUZUKI, M. NAKAMURA, H. MATSUBARA, H. K. SHELDON, K. J. HALEY, C. M. LILLY, et al.
Cyclooxygenase-2 Expression during Allergic Inflammation in Guinea-Pig Lungs
Am. J. Respir. Crit. Care Med.,
February 1, 2002;
165(3):
382 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tamaoki, M. Kondo, J. Nakata, Y. Nagano, K. Isono, and A. Nagai
Effect of a Thromboxane A2 Antagonist on Sputum Production and Its Physicochemical Properties in Patients With Mild to Moderate Asthma
Chest,
July 1, 2000;
118(1):
73 - 79.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the European Respiratory Society.
|